首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. B
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. B
admin
2013-01-25
82
问题
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. But their target isn’t breast cancer, osteoporosis, or a similarly well-known affliction. Despite its alarming impact on its victims, the malady in question has received comparatively little medical scrutiny. It’s a "hidden epidemic," according to the Stanford researchers: compulsive shopping disorder.
That’s right. What was once merely a punchline in television sitcoms is now being taken seriously by many clinicians. According to the Stanford study’s leader, Dr. Lorrin Koran, compulsive shopping is "motivated by ’irresistible’ impulses, characterized by spending that is excessive and inappropriate, has harmful consequences for the individual, and tends to be chronic and stereotyped." Compulsive shoppers "binge buy" --most often clothes, shoes, makeup, and jewelry--and then suffer intense guilt. That, in turn, helps trigger another frenzied trip to the mall, and the cycle continues.
Could compulsive shopping be a health hazard associated with America’s unparalleled economic prosperity? "It seems to be a disease of affluence," says Dr. Jerrold Pollak, a clinical psychologist who’s treated several shopaholics. "Advertisers... would like us to think that shopping is a reason to live," agrees Dr. Cheryl Carmin, another clinical psychologist. "If you do not have the time or inclination to go to the mall or grocery store, there are catalogs, delivery services, home shopping networks on TV, and endless items to buy via the Internet." Indeed, this year, US advertisers will spend $ 233 billion--an amount equal to six federal education budgets to persuade Americans to buy, buy, buy.
Yet the possibility that US advertisers may be driving certain women in our society t9 psychosis is only part of the story. It seems that the pharmaceutical companies’ quest to cure the effects of excessive marketing may itself be little more than a cleverly-disguised marketing scheme. The Stanford study, like many of its kind, is being funded by a pharmaceutical company. The undisclosed drug is an FDA-approved antidepressant, specifically an SSRI--a selective serotonin re-uptake inhibitor. (The researchers are also studying behavioral therapies for compulsive shoppers.)
The researchers running the Stanford study refused to reveal their sponsor. However, only five SSRIs are currently on the US market. Pfizer (makers of Zolofi), Eli Billy (Prozac) and SmithKline Beecham (Paxil) all reported that they are neither conducting nor planning any studies of their drugs for compulsive shopping. Solvay (Luvox)also seems an unlikely candidate. In 1997, researchers at the University of Iowa tried using Luvox to treat compulsive shoppers and found no measurable differences between the effects of the drug and those of a placebo. Perhaps the manufacturers of Luvox want to give their product another shot. More likely, however, the mysterious benefactor of the Stanford Study is Forest Pharmaceuticals (Celexa). Their PR department neither confirmed nor denied any involvement in Koran’s study.
Why would a pharmaceutical company anonymously spend money to license one of its top-selling drugs for a marginal disorder like compulsive shopping? A big part of the answer is profit. The mystery company presumably hopes to carve a unique slice out of the mental disorder pie in order to market it together with a ready-made treatment. This is not at all a new strategy for the world’s mammoth pharmaceutical firms, as David Healy, a professor at the University of Wales College of Medicine, explains in his book "The Anti- Depressant Em." Healy’s book describes a process by which companies Seek to "educate" both patients and clinicians about a new disorder, to sell the disorder in preparation for selling its cure. Funding clinical trials is a crucial part of that process.
The manufacturer of which of the following SSRIs is most possibly the sponsor of the Stanford study?
选项
A、Zolofi.
B、Prozac.
C、Luvox.
D、Celexa.
答案
D
解析
该题要求理解第五段的内容。不难看出,D项为正确答案。
转载请注明原文地址:https://www.kaotiyun.com/show/hm1O777K
0
考博英语
相关试题推荐
Hisattentionoften_____atlectures,nowonderhefailedtheexam.
Allofuswereimpressedbyher_______complexioa
Thepercentageofimmigrants(includingthoseunlawfullypresent)intheUnitedStateshasbeencreepingupwardforyears.At12
Tounderstandthemarketingconcept,itisonlynecessarytounderstandthedifferencebetweenmarketingandselling.Nottooma
Therelationshipbetweenformaleducationandeconomicgrowthinpoorcountriesiswidelymisunderstoodbyeconomistsandpoliti
Whenthewillandconscienceoftheinternationalcommunityisdefied,wewillact—withpeacefuldiplomacywheneverpossible,with
Thisspaciousroomis____furnishedwithjustafewarticlesinit.
Thisspaciousroomis________furnishedwithjustafewarticlesinit
71.ItwasnotuntilmodernscholarshipuncoveredthesecretofreadingMiddleEnglishthatwecouldunderstandthatChaucer,far
Dogsaresocialanimalsandwithoutpropertraining,theywillbehavelikewildanimals.Theywillspoilyourhouse,destroyyo
随机试题
钢铁材质的简易鉴别方法有________鉴别法、________鉴别法。
去年夏天洪水期间,不得不动员全国的力量来救灾。
A.1~2年B.2~4年C.3~12个月D.1~2周E.2~3天骨折后,骨样组织逐渐骨化,形成骨性骨痂需要的时间是
以下关于进口设备交货方式的说法中,正确的是()。
大海公司当期发生研究开发支出共计500万元,其中研究阶段支出100万元,开发阶段不符合资本化条件的支出120万元,开发阶段符合资本化条件的支出280万元,假定大海公司研发形成的无形资产在当期达到预定用途,并在当期摊销10万元。假定会计摊销方法、摊销年限和净
,()
阅读以下文字。完成下列问题。转基因食品是指利用现代分子生物技术,把动植物的基因加以改变,再制造出具备新特征的食品种类。其优点显著,但转基因食品存在很多不容忽视的存在的或潜在的危害性。新基因的转入,打破了原来生物基因的“管理体制”,使一些
通过指针链来表示和实现实体之间联系的模型是
改善
RainforestsmakeupaboutsixpercentoftheEarth’ssurfaceandtheyareveryimportanttous.Theyprovideuswithmuchofthe
最新回复
(
0
)